Expression of S100A2 and S100A4 Predicts for Disease Progression and Patient Survival in Bladder Cancer

Urology

Volumn 70, Issue 3, 2007, Pages 602-607

  Matsumoto, Kazumasa ^a   Irie, Akira ^a   Satoh, Takefumi ^a   Ishii, Junichiro ^a   Iwabuchi, Keiichi ^a   Iwamura, Masatsugu ^a   Egawa, Shin ^b   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK; SCALE UP; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTACTIC FACTORS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 34648835332     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.04.007     Document Type: Article

References (27)

1. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33 (2001) 637-668
2. Heizmann C.W. The multifunctional S100 protein family. Methods Mol Biol 172 (2002) 69-80
3. Lee S.W., Tomasetto C., Swisshelm K., et al. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89 (1992) 2504-2508
4. Vellucci V.F., Germino F.J., and Reiss M. Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. Gene 166 (1995) 213-220
5. Lauriola L., Michetti F., Maggiano N., et al. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma. Int J Cancer 89 (2000) 345-349
6. Liu D., Rudland P.S., Sibson D.R., et al. Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer 83 (2000) 1473-1479
7. Sherbet G.V., and Lakshmi M.S. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 18 (1998) 2415-2421
8. Grigorian M.S., Tulchinsky E.M., Zain S., et al. The mts1 gene and control of tumor metastasis. Gene 135 (1993) 229-238
9. De Vouge M.W., and Mukherjee B.B. Transformation of normal rat kidney cells by v-K-ras enhances expression of transin 2 and an S-100-related calcium-binding protein. Oncogene 7 (1992) 109-119
10. Jones C.J., Shaw J.J., Wyllie F.S., et al. High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines. Mol Cell Endocrinol 116 (1996) 115-119
11. Takenaga K., Nakanishi H., Wada K., et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res 3 (1997) 2309-2316
12. Schuyer M., Henzen-Logmans S.C., van der Burg M.E., et al. Genetic alterations in ovarian borderline tumours and ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol 82 (1999) 147-150
13. Kimura K., Endo Y., Yonemura Y., et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16 (2000) 1125-1131
14. Rudland P.S., Platt-Higgins A., Renshaw C., et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60 (2000) 1595-1603
15. Yonemura Y., Endou Y., Kimura K., et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6 (2000) 4234-4242
16. Ninomiya I., Ohta T., Fushida S., et al. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol 18 (2001) 715-720
17. Davies B.R., O'Donnell M., Durkan G.C., et al. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 196 (2002) 292-299
18. Matsubara D., Niki T., Ishikawa S., et al. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes. Cancer Sci 96 (2005) 844-857
19. Agerbaek M., Alsner J., Marcussen N., et al. Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients. Eur Urol 50 (2006) 777-785
20. Tumours of the urinary systems. In: Eble J.N., Sauter G., Epstein J.I., et al. (Eds). WHO Classification: Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon 89-157
21. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51 (2007) 152-160
22. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448 (1998) 190-199
23. Sun Y. Identification and characterization of genes responsive to apoptosis: application of DNA chip technology and mRNA differential display. Histol Histopathol 15 (2000) 1271-1284
24. Tan M., Heizmann C.W., Guan K., et al. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett 445 (1999) 265-268
25. Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA 102 (2005) 4735-4740
26. Davies M.P., Rudland P.S., Robertson L., et al. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13 (1996) 1631-1637
27. Levett D., Flecknell P.A., Rudland P.S., et al. Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. Am J Pathol 160 (2002) 693-700